Profile
Thomas Lategan formerly worked at The Medicines Co., as Vice President-Regulatory Affairs from 1997 to 2000, Panacos Pharmaceuticals, Inc., as Vice President-Regulatory Affairs from 2007 to 2008, NeurAxon, Inc., as Vice President-Regulatory Affairs from 2008 to 2015, Actelion Pharmaceuticals US, Inc., as Vice President-Regulatory Affairs from 2000 to 2007, Roche Corp., as Principal, and Bright Minds Biosciences, Inc., as Vice President-Regulatory Affairs.
Dr. Lategan received his doctorate degree from the University of Oxford and undergraduate degree from the University of Aberdeen.
Former positions of Thomas Lategan
| Companies | Position | End |
|---|---|---|
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | General Counsel | 31/10/2015 |
| PANACOS PHARMACEUTICALS, INC. | General Counsel | 31/08/2008 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | General Counsel | 31/01/2007 |
| THE MEDICINES COMPANY | General Counsel | 31/01/2000 |
| BRIGHT MINDS BIOSCIENCES INC. | General Counsel | - |
Training of Thomas Lategan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panacos Pharmaceuticals, Inc.
Panacos Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
NeurAxon, Inc.
NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and markets drugs | Health Technology |
Roche Corp. | |
Bright Minds Biosciences, Inc.
Bright Minds Biosciences, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Stock Market
- Insiders
- Thomas Lategan
















